Skip to content
healthcare.dev

Azacitidine

NDC 70069-857, Azacitidine, injection, powder, lyophilized, for solution, from Somerset Therapeutics LLC.

Product NDC
70069-857
Status
Listed
Labeler
Somerset Therapeutics LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217453
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-857 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
70069-857-01700690857011 VIAL, GLASS in 1 CARTON (70069-857-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3bc4f406-2ec7-7169-e063-6394a90a81d9

Use it

Look up 70069-857 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-857 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-857. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.